Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 17Tumor-Agnostic 15Other hematologic neoplasm 13Plasma cell 12Thoracic 10Lymphoid 8Breast 7Gynecologic 4Sarcoma 3Genitourinary 3Dermatologic 3Head & Neck 2NET 1Endocrine 1CNS 1

Conditions

Brain Neoplasms 405Glioma 261Glioblastoma 204Central Nervous System Neoplasms 92Neoplasms 87Neuroblastoma 82Astrocytoma 72Neurofibromatosis 1 55Breast Neoplasms 52Meningioma 51Lung Neoplasms 42Oligodendroglioma 39Head and Neck Neoplasms 35Medulloblastoma 33Spinal Cord Neoplasms 30Sarcoma 30Leukemia 30Paraganglioma 29Pheochromocytoma 28Lymphoma 28Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 24Neuroma, Acoustic 24Ependymoma 24Melanoma 22Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Ovarian Neoplasms 20Neoplasm Metastasis 19Lymphoma, Non-Hodgkin 19

Interventions

Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasm, Residual × CNS × Clear all
NCT05850377 2023-05-09

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Sociedad de Lucha Contra el Cáncer del Ecuador

Unknown
90 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡